[HTML][HTML] Cost–utility analysis of using high-intensity statin among post-hospitalized acute coronary syndrome patients
PEN Dewi, M Thavorncharoensap… - The Egyptian Heart …, 2024 - Springer
Background Post-hospitalized acute coronary syndrome (ACS) patients in Indonesia
National Insurance does not pay for the use of high-intensity statin (HIS) for secondary …
National Insurance does not pay for the use of high-intensity statin (HIS) for secondary …
[HTML][HTML] Relationships between beliefs about statins and non-adherence in inpatients from Northwestern China: a cross-sectional survey
H Li, X Jia, H Min, Y Zhang, H Wang… - Frontiers in …, 2023 - frontiersin.org
Background: Studies have identified patients' beliefs about medicines as an important
determinant of non-adherence. However, scant data are available on the possible …
determinant of non-adherence. However, scant data are available on the possible …
Statin Discontinuation: Global Challenge in Secondary Prevention
Statin therapy is widely acknowledged as an essential medication for the secondary
prevention of cardiovascular disease, demonstrating theoretical efficacy and safety. 2 …
prevention of cardiovascular disease, demonstrating theoretical efficacy and safety. 2 …